Autoimmune Diseases

PDF
Autoimmune Diseases / 2012 / Article

On this page

Copyright
Review ArticleErratum
Review ArticleErratum

Erratum | Open Access

Volume 2012 |Article ID 734069 | 1 page | https://doi.org/10.1155/2012/734069

Erratum to: A Systematic Review of Serum Biomarkers Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor as Tests for Rheumatoid Arthritis

Peter C. Taylor,1 Juliane Gartemann,2 Jeanie Hsieh,2 and James Creeden 2

1Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford Botnar Research Centre, Windmill Road Headington, Oxford OX3 7LD, UK

2Roche Diagnostics, Ltd., Forrenstraße, 6343 Rotkreuz, Switzerland

Received06 Nov 2011
Accepted20 Nov 2011
Published19 Jan 2012
Number of points01235
Joint involvement1 medium-large joint2–10 medium-large joints1–3 small joints4–10 small joints>10 small joints
SerologyNegative for both RF and anti-CCPPositive for either RF or anti-CCP at low titer (between 1x–3x upper limit of normal)Positive for either RF or anti-CCP at high titer (>3x upper limit of normal)
Duration of synovitis<6 weeks≥6 weeks
Acute phase reactantsNormal CRP and ESRAbnormal CRP or ESR
Source:
Table 3 
2010 ACR/EULAR scoring criteria for RA. The following table provides the scoring criteria for different domains of evaluation. For each cell in the table for which the patient satisfies the condition, the cell is scored by the number of points at the top of the column in which it is found. The patient’s score is the sum of the scores for the individual cells. Patients with a total score of 6 or more points are diagnosed as having RA.

Copyright © 2012 Peter C. Taylor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

802 Views | 519 Downloads | 0 Citations
PDF Download Citation Citation
Download other formatsMore
ePub
XML
Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.